Fosrenol Side Effects

Generic name: lanthanum carbonate

Note: This document contains side effect information about lanthanum carbonate. Some of the dosage forms listed on this page may not apply to the brand name Fosrenol.

Some side effects of Fosrenol may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

For the Consumer

Applies to lanthanum carbonate: oral tablet chewable

Get emergency medical help if you have any of these signs of an allergic reaction while taking lanthanum carbonate (the active ingredient contained in Fosrenol) hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using lanthanum carbonate and call your doctor at once if you have a serious side effect such as severe stomach pain or severe constipation.

Less serious side effects of lanthanum carbonate may include:

• nausea or vomiting;

• diarrhea or constipation; or

• stomach pain.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For Healthcare Professionals

Applies to lanthanum carbonate: oral tablet chewable

Gastrointestinal

Gastrointestinal side effects (including nausea, vomiting, and diarrhea) were the most prominent reasons for discontinuation of therapy in clinical studies.

One study reported incidence of nausea and vomiting as high as 16% and 18%, respectively.

Gastrointestinal side effects have frequently included nausea (11%, compared to 5% with placebo), vomiting (9%, compared to 4% with placebo), abdominal pain (5%, compared to 0% with placebo), diarrhea (13% to 23%), and constipation (6% to 14%). Postmarketing gastrointestinal side effects have included dyspepsia.

Cardiovascular

Cardiovascular side effects have included hypotension (8% to 16%).

Respiratory

Respiratory side effects have included bronchitis (5%) and rhinitis (5% to 7%).

Other

Other side effects have included dialysis graft complication (3% to 26%), headache (5% to 21%), and dialysis graft occlusion (4% to 21%). Other side effects reported postmarketing have included tooth injury.

Metabolic

Metabolic side effects have included hypercalcemia (up to 4%). Metabolic side effects reported postmarketing have included hypophosphatemia and hypocalcemia (up to 5%).

Dermatologic

Dermatologic side effects reported postmarketing have included allergic skin reactions.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.